Search

Your search keyword '"Kamboj, Mini"' showing total 580 results

Search Constraints

Start Over You searched for: Author "Kamboj, Mini" Remove constraint Author: "Kamboj, Mini"
580 results on '"Kamboj, Mini"'

Search Results

1. Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma

2. ASO Visual Abstract: Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma

4. Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile

10. Risk of Surgical Site Infection (SSI) following Colorectal Resection Is Higher in Patients With Disseminated Cancer: An NCCN Member Cohort Study.

12. Vaccination of Adults With Cancer: ASCO Guideline

13. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy

14. Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer

16. Management of a major varicella zoster exposure in a pediatric oncology population.

17. Vaccination of Adults With Cancer: ASCO Guideline Clinical Insights.

21. SARS-CoV-2 surveillance testing and isolation management of immunocompromised patients: Survey results from 13 health care centers in the United States.

22. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

23. Determinants of COVID-19 disease severity in patients with cancer

24. Clonal hematopoiesis is associated with risk of severe Covid-19

29. Outcomes and Management of the SARS-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy

31. Risk for Clostridioides difficile Infection among Older Adults with Cancer

35. Prevalence of Enteric Infections in Patients on Immune Checkpoint Inhibitors and Impact on Management and Outcomes.

37. Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing

38. Cellular Therapy During COVID-19: Lessons Learned and Preparing for Subsequent Waves

40. Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients

41. Data from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

42. Supplemental Table 3A&3B from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

43. Supplemental Table 1 from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

44. Supplementary Table and Figures from Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies

45. Data from Disease- and Therapy-Specific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies

46. Supplemental Table 2A&2B from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy

Catalog

Books, media, physical & digital resources